Movement Alert｜Insilico Medicine Falls 5.21% in Regular Trading, Abu Dhabi Secondary Listing Expectations Dashed Amid Lock-up Expiry Pressure

Market Focus06-04

On June 4, Insilico Medicine fell 5.21% in regular trading, trading at HK$38.66/share, with trading volume of HK$22.72 million. The stock has extended its recent downtrend, with cumulative losses approaching 40% over the past month.

On the news front, the company previously issued a voluntary announcement on May 27 clarifying that it currently has no definitive plan for a secondary listing in Abu Dhabi. The market had earlier anticipated this move would help expand international financing channels and deepen its Middle East strategic presence, and the dashed expectations continue to weigh on sentiment.

More critically, having listed on the Hong Kong Stock Exchange in December last year, the company has now formally entered its lock-up expiry window. Shares held by certain cornerstone investors and employee equity incentive plans are approaching their release dates, intensifying market concerns over potential selling pressure. Additionally, the Life Sciences Tools and Services sector showed broad weakness today, with WUXI BIO down 0.55%, WUXI APPTEC down 0.95%, GenScript Bio down 2.76%, and XTALPI down 1.03%, further dragging on the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180676220?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 09:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180676220","market":"us","top_or_hot":-1,"title":"Movement Alert｜Insilico Medicine Falls 5.21% in Regular Trading, Abu Dhabi Secondary Listing Expectations Dashed Amid Lock-up Expiry Pressure","media":"Market Focus","content":"<p><p>On June 4, Insilico Medicine fell 5.21% in regular trading, trading at HK$38.66/share, with trading volume of HK$22.72 million. The stock has extended its recent downtrend, with cumulative losses approaching 40% over the past month.</p><p>On the news front, the company previously issued a voluntary announcement on May 27 clarifying that it currently has no definitive plan for a secondary listing in Abu Dhabi. The market had earlier anticipated this move would help expand international financing channels and deepen its Middle East strategic presence, and the dashed expectations continue to weigh on sentiment.</p><p>More critically, having listed on the Hong Kong Stock Exchange in December last year, the company has now formally entered its lock-up expiry window. Shares held by certain cornerstone investors and employee equity incentive plans are approaching their release dates, intensifying market concerns over potential selling pressure. Additionally, the Life Sciences Tools and Services sector showed broad weakness today, with WUXI BIO down 0.55%, WUXI APPTEC down 0.95%, GenScript Bio down 2.76%, and XTALPI down 1.03%, further dragging on the stock.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Insilico Medicine Falls 5.21% in Regular Trading, Abu Dhabi Secondary Listing Expectations Dashed Amid Lock-up Expiry Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Insilico Medicine Falls 5.21% in Regular Trading, Abu Dhabi Secondary Listing Expectations Dashed Amid Lock-up Expiry Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-04 09:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 4, Insilico Medicine fell 5.21% in regular trading, trading at HK$38.66/share, with trading volume of HK$22.72 million. The stock has extended its recent downtrend, with cumulative losses approaching 40% over the past month.</p><p>On the news front, the company previously issued a voluntary announcement on May 27 clarifying that it currently has no definitive plan for a secondary listing in Abu Dhabi. The market had earlier anticipated this move would help expand international financing channels and deepen its Middle East strategic presence, and the dashed expectations continue to weigh on sentiment.</p><p>More critically, having listed on the Hong Kong Stock Exchange in December last year, the company has now formally entered its lock-up expiry window. Shares held by certain cornerstone investors and employee equity incentive plans are approaching their release dates, intensifying market concerns over potential selling pressure. Additionally, the Life Sciences Tools and Services sector showed broad weakness today, with WUXI BIO down 0.55%, WUXI APPTEC down 0.95%, GenScript Bio down 2.76%, and XTALPI down 1.03%, further dragging on the stock.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1180676220","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180676220","pubTimestamp":1780538103,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 4, Insilico Medicine fell 5.21% in regular trading, trading at HK$38.66/share, with trading volume of HK$22.72 million. The stock has extended its recent downtrend, with cumulative losses...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"动向提示|英矽智能常规交易跌5.21%禁售到期压力下阿布扎比二次上市预期破灭","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On June 4, Insilico Medicine fell 5.21% in regular trading, trading at HK$38.66/share, with trading volume of HK$22.72 million. The stock has extended its recent downtrend, with cumulative losses approaching 40% over the past month.On the news front, the company previously issued a voluntary announcement on May 27 clarifying that it currently has no definitive plan for a secondary listing in Abu Dhabi. The market had earlier anticipated this move would help expand international financing channels and deepen its Middle East strategic presence, and the dashed expectations continue to weigh on sentiment.More critically, having listed on the Hong Kong Stock Exchange in December last year, the company has now formally entered its lock-up expiry window. Shares held by certain cornerstone investors and employee equity incentive plans are approaching their release dates, intensifying market concerns over potential selling pressure. Additionally, the Life Sciences Tools and Services sector showed broad weakness today, with WUXI BIO down 0.55%, WUXI APPTEC down 0.95%, GenScript Bio down 2.76%, and XTALPI down 1.03%, further dragging on the stock.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180676220","isCrawlerRequest":true}